Displaying One Session

Room B Educational session
Date
11.04.2018
Time
14:30 - 16:00
Location
Room B
Chairs
  • Juergen Wolf (DE)
  • Tony S.K. Mok (HK)
First line for oncogene addicted lung cancer Educational session

Is PFS still a relevant endpoint for first-line TKIs?

Lecture Time
14:30 - 14:50
Presenter
  • Suresh S. Ramalingam (US)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Suresh S. Ramalingam (US)
First line for oncogene addicted lung cancer Educational session

First vs second vs third generation EGFR TKI

Lecture Time
14:50 - 15:10
Presenter
  • Juergen Wolf (DE)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Juergen Wolf (DE)
First line for oncogene addicted lung cancer Educational session

Key factors that determine the selection of first-line ALK inhibtiors

Lecture Time
15:10 - 15:30
Presenter
  • Fiona H. Blackhall (GB)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Fiona H. Blackhall (GB)
First line for oncogene addicted lung cancer Educational session

The role of first-line combination therapy for oncogene addicted lung cancer

Lecture Time
15:30 - 15:50
Presenter
  • Takashi Seto (JP)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00
Authors
  • Takashi Seto (JP)
First line for oncogene addicted lung cancer Educational session

Q&A

Lecture Time
15:50 - 16:00
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
11.04.2018
Time
14:30 - 16:00